Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd.

SEHK:2566 Stock Report

Market Cap: HK$1.5b

Hangzhou Jiuyuan Genetic Biopharmaceutical Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Hang Fu

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure11.3yrs
CEO ownershipn/a
Management average tenure2.3yrs
Board average tenure1.7yrs

Recent management updates

No updates

Recent updates

CEO

Hang Fu (61 yo)

11.3yrs

Tenure

Mr. Hang Fu is Executive Chairman of Hangzhou Jiuyuan Gene Engineering Co. Ltd. from January 2024 and its General Manager since January 2014 and has been its Chairman of the Board since November 2023 and i...

Leadership Team

NamePositionTenureCompensationOwnership
Hang Fu
Executive Chairman & GM11.3yrsno datano data
Yanmei Yang
Financial Controller1.4yrsno datano data
Hui Li
Deputy GM & Chief Manager of Manufacturing Center3.1yrsno datano data
Zhou Wei
Deputy GMno datano datano data
Handong Sun
Deputy GM and Chief Manager of the Research & Development center7.5yrsno datano data
Xiu Huang
Secretary to the Board & Joint company secretary1.4yrsno datano data
Wing Nga Ho
Joint Company Secretaryless than a yearno datano data

2.3yrs

Average Tenure

51yo

Average Age

Experienced Management: 2566's management team is considered experienced (2.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Hang Fu
Executive Chairman & GM25.2yrsno datano data
Zhou Wei
Deputy GM5.9yrsno datano data
Albert Esteve Cruella
Non-executive Director17.8yrsno datano data
Demin Zhou
Independent Non-Executive Director1.4yrsno datano data
Junjie Fei
Non-executive Director1.9yrsno datano data
Fei Zhao
Employee Representative Supervisor1.4yrsno datano data
Jiancai Ye
Chairman of the Supervisory Committee1.4yrsno datano data
Feihu Xu
Supervisor1.4yrsno datano data
Honglan Ma
Non-executive Director3.5yrsno datano data
Zhihu Zhou
Independent Non-Executive Director1.4yrsno datano data
Mei Yi Ho
Independent Non-Executive Director1.4yrsno datano data
Shihang Wu
Non-executive Director3.5yrsno datano data

1.7yrs

Average Tenure

50.5yo

Average Age

Experienced Board: 2566's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/04/11 11:43
End of Day Share Price 2025/04/11 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Hangzhou Jiuyuan Genetic Biopharmaceutical Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.